Back to top
more

PureTech Health (PRTC)

(Delayed Data from NSDQ)

$27.89 USD

27.89
458

-0.61 (-2.14%)

Updated Apr 30, 2024 03:10 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value F Growth B Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (79 out of 251)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for PRTC

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for PureTech Health PLC Sponsored ADR falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 327 350 481 404 162
Receivables 14 22 8 3 2
Notes Receivable 0 0 0 0 0
Inventories 0 0 0 0 0
Other Current Assets 6 14 13 8 4
Total Current Assets 347 386 502 414 169
Net Property & Equipment 10 23 27 23 21
Investments & Advances 326 278 397 530 726
Other Non-Current Assets 0 1 1 2 2
Deferred Charges 0 0 0 0 0
Intangibles 1 1 1 1 1
Deposits & Other Assets 1 0 1 0 0
Total Assets 694 703 946 990 941
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 4 2 4 26 1
Accounts Payable 44 55 36 22 20
Current Portion Long-Term Debt 0 5 1 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 0 0 0 0 0
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 30 182 129 115
Total Current Liabilities 51 97 226 181 139
Mortgages 0 0 0 0 0
Deferred Taxes/Income 52 20 90 109 117
Convertible Debt 0 0 0 0 0
Long-Term Debt 0 10 14 15 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 114 4 3 0 0
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 236 155 362 336 291
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 5 5 5 5 5
Capital Surplus 290 290 289 289 288
Retained Earnings 84 150 200 260 254
Other Equity 123 129 90 99 103
Treasury Stock 45 26 0 0 0
Total Shareholder's Equity 458 548 584 654 650
Total Liabilities & Shareholder's Equity 694 703 946 990 941
Total Common Equity 458 548 584 654 650
Shares Outstanding 27.05 27.89 28.70 28.50 NA
Book Value Per Share 16.94 19.63 20.35 22.93 -0.01

Fiscal Year End for PureTech Health PLC Sponsored ADR falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 327 -99,999 -99,648 -99,999
Receivables NA 14 NA 2 NA
Notes Receivable NA 0 NA NA NA
Inventories NA 0 NA NA NA
Other Current Assets NA 6 NA 7 NA
Total Current Assets NA 347 NA 360 NA
Net Property & Equipment NA 10 NA 11 NA
Investments & Advances NA 326 NA 310 NA
Other Non-Current Assets NA 0 NA 0 NA
Deferred Charges NA 0 NA NA NA
Intangibles NA 1 NA 1 NA
Deposits & Other Assets NA 1 NA 1 NA
Total Assets NA 694 NA 694 NA
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 4 NA 2 NA
Accounts Payable NA 44 NA 31 NA
Current Portion Long-Term Debt NA 0 NA NA NA
Current Portion Capital Leases NA 0 NA NA NA
Accrued Expenses NA 0 NA NA NA
Income Taxes Payable NA 0 NA 12 NA
Other Current Liabilities NA 0 NA 0 NA
Total Current Liabilities NA 51 NA 49 NA
Mortgages NA 0 NA NA NA
Deferred Taxes/Income NA 52 NA 9 NA
Convertible Debt NA 0 NA NA NA
Long-Term Debt NA 0 NA NA NA
Non-Current Capital Leases NA 0 NA NA NA
Other Non-Current Liabilities NA NA 106 NA
Minority Interest (Liabilities) NA 0 NA NA NA
Total Liabilities NA 236 NA 185 NA
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 NA NA NA
Common Stock (Par) NA 5 NA 5 NA
Capital Surplus NA 290 NA 290 NA
Retained Earnings NA 84 NA 125 NA
Other Equity NA 123 NA 122 NA
Treasury Stock NA 45 NA 33 NA
Total Shareholder's Equity NA 458 NA 509 NA
Total Liabilities & Shareholder's Equity NA 694 NA 694 NA
Total Common Equity 0 458 0 100,508 0
Shares Outstanding 27.00 27.05 27.30 27.60 27.80
Book Value Per Share 0.00 16.94 0.00 3,641.59 0.00